Related references
Note: Only part of the references are listed.Delta-9-Tetrahydrocannabinol (a†9-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats
Noor Azuin Suliman et al.
NEUROTOXICITY RESEARCH (2018)
Heart Disease and Stroke Statistics-2018 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2018)
Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample
Aditi Kalla et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2018)
Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury
Justin R. Piro et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Marc P. Baggelaar et al.
PROGRESS IN LIPID RESEARCH (2018)
Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke
Sang-Ho Choi et al.
STROKE (2018)
The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next
Rita Rubin
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders
Justin S. Cisar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45000 Swedish Men
Daniel Falkstedt et al.
STROKE (2017)
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)
Carlotta Granchi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice
Andras Bilkei-Gorzo et al.
NATURE MEDICINE (2017)
A randomised controlled cross-over double-blind pilot study protocol on THC: CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity
Lucio Marinelli et al.
BMJ OPEN (2017)
A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
Salahaden R. Sultan et al.
FRONTIERS IN PHARMACOLOGY (2017)
A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study
Khalid A. Jadoon et al.
JCI INSIGHT (2017)
What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review
Emilie Jouanjus et al.
CURRENT ATHEROSCLEROSIS REPORTS (2017)
Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity
Gillian M. Keating
DRUGS (2017)
Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPAR and 5-HT1A receptors
William H. Hind et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease
Jose Luis Lopez-Sendon Moreno et al.
JOURNAL OF NEUROLOGY (2016)
Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States
Kavelin Rumalla et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis
William N. Whiteley et al.
LANCET NEUROLOGY (2016)
Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and infl ammation
Angel Chamorro et al.
LANCET NEUROLOGY (2016)
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
Demetrios Moris et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Cannabinoids in experimental stroke: a systematic review and meta-analysis
Timothy J. England et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
Javier Fernandez-Ruiz et al.
NEUROTHERAPEUTICS (2015)
Tetrahydrocannabinol Induces Brain Mitochondrial Respiratory Chain Dysfunction and Increases Oxidative Stress: A Potential Mechanism Involved in Cannabis-Related Stroke
Valerie Wolff et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Adverse Cardiovascular, Cerebrovascular, and Peripheral Vascular Effects of Marijuana Inhalation: What Cardiologists Need to Know
Grace Thomas et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Cannabis-Associated Angiopathy An Uncommon Cause of Crescendo Transient Ischemic Attacks
Georgios Tsivgoulis et al.
CIRCULATION (2014)
Evaluation of NHS Carbamates as a Potent and Selective Class of Endocannabinoid Hydrolase Inhibitors
Micah J. Niphakis et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Highly Selective Inhibitors of Monoacylglycerol Lipase Bearing a Reactive Group that Is Bioisosteric with Endocannabinoid Substrates
Jae Won Chang et al.
CHEMISTRY & BIOLOGY (2012)
Significance of Brain Tissue Oxygenation and the Arachidonic Acid Cascade in Stroke
Cameron Rink et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Daniel K. Nomura et al.
SCIENCE (2011)
Possible Anandamide and Palmitoylethanolamide involvement in human stroke
Marcello Naccarato et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Occurence and Clinical Predictors of Spasticity After Ischemic Stroke
Peter P. Urban et al.
STROKE (2010)
A systematic review of clinical trials of pharmacological interventions for acute ischaemic stroke (1955-2008) that were completed, but not published in full
Lorna M. Gibson et al.
TRIALS (2010)
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
Kazuhide Hayakawa et al.
PHARMACEUTICALS (2010)
Therapeutic Time Window of Cannabidiol Treatment on Delayed Ischemic Damage via High-Mobility Group Box1-Inhibiting Mechanism
Kazuhide Hayakawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Jonathan Z. Long et al.
NATURE CHEMICAL BIOLOGY (2009)
Role of cannabinoids and endocannabinoids in cerebral ischemia
Cecilia J. Hillard
CURRENT PHARMACEUTICAL DESIGN (2008)
Potency of Delta(9)-THC and other cannabinoids in cannabis in England in 2005: Implications for psychoactivity and pharmacology
David J. Potter et al.
JOURNAL OF FORENSIC SCIENCES (2008)
Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets
Francisco J. Alvarez et al.
PEDIATRIC RESEARCH (2008)
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption
Mohanraj Rajesh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Hyperresponsiveness of platelets in ischemic stroke
Suzanne Fateh-Moghadam et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Δ9-tetrahydrocannabinol (Δ9-THC) Prevents cerebral infarction via hypothalamic-independent hypothermia
Kazuhide Hayakawa et al.
LIFE SCIENCES (2007)
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
D Panikashvili et al.
NEUROBIOLOGY OF DISEASE (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial
AIR Maas et al.
LANCET NEUROLOGY (2006)
Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism
K Mishima et al.
STROKE (2005)
The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets
E Deusch et al.
ANESTHESIA AND ANALGESIA (2004)
Drug-induced hypothermia reduces ischemic damage - Effects of the cannabinoid HU-210
RR Leker et al.
STROKE (2003)
Increased severity of stroke in CB1 cannabinoid receptor knock-out mice
S Parmentier-Batteur et al.
JOURNAL OF NEUROSCIENCE (2002)
Cognitive functioning of long-term heavy cannabis users seeking treatment
N Solowij et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
